- NYC comptroller wants pharmacies to offer abortion pill
- Investor support for abortion-related bids fell in 2023
New York City Comptroller Brad Lander cautioned against the financial risks associated with a delay. Pharmacies that do not dispense abortion pills risk losing investor confidence, Lander warned in letters to the CEOs of the five companies Monday.
Lander oversees New York City’s pension funds, which collectively hold more than $1.32 billion in shares of Walmart, Costco, Kroger, Albertsons, and McKesson. Representatives from the companies did not immediately respond to requests for comment.
“[Investor] concerns include the company’s responsiveness to a growing market opportunity, its mitigation of potential reputational risks, and its commitment to maximizing sales and long-term shareholder value,” Lander wrote in the letters made public Wednesday.
Both
The comptroller’s request comes after Democratic lawmakers called on the retail companies to begin dispensing the drug.
Lander cited a brief by thousands of medical professionals that compares mifepristone’s safety profile to ibuprofen, and included a study from Global Markets Insight Inc. that valued the abortion pill market at over $24.4 billion.
Investors have voted on dozens of abortion-related proposals in the past few years, with shareholder support for the bids dropping 50% between 2022 and 2023.
To contact the reporter on this story:
To contact the editors responsible for this story:
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.